Synapse Open Synapse
Biology

Illumina Offers Early Access to Duplex Sequencing for MRD, Tumor Evolution Research

GEN · · 2 min read

Illumina has announced an early access program to a duplex sequencing workflow that reads both DNA strands to detect trace ctDNA in molecular residual disease and tumor evolution studies. Kits are expected in early 2027.

Latest from GEN